CAS RN: 1746-01-6

Carcinogenicity Evidence

Evaluation: There is limited evidence in humans for the carcinogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. There is sufficient evidence in experimental animals for the carcinogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Overall Evaluation: 2,3,7,8-tetrachlorodibenzo-p-dioxin is carcinogenic to humans (Group 1). In making the overall evaluation, the Working Group took into consideration the following supporting evidence: (1) 2,3,7,8-TCDD is a multi-site carcinogen in experimental animals that has been shown by several lines of evidence to act through a mechanism involving the Ah receptor; (2) this receptor is highly conserved in an evolutionary sense and functions the same way in humans as in experimental animals; (3) tissue concentrations are similar in both heavily exposed human populations in which an increased overall cancer risk was observed and in rats exposed to carcinogenic dosage regimens in bioassays.
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is known to be a human carcinogen based on sufficient evidence of carcinogenicity from studies on humans, both epidemiological and on the mechanism of carcinogenesis.
Find more information on this substance at: PubChem, PubMed